Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
Maegi Medicine: First-in-class Immune Gene Therapy for Human Health
Sidi Chen, Ph.D. -
Athena Therapeutics
Ranjit S. Bindra, M.D., Ph.D. -
-
Antibody-mediated gene editing and DNA/RNA delivery
Peter M. Glazer, M.D., Ph.D. -
Biologically Selective Drug-Eluting Stent
Laura Niklason, PhD, MD -
Apeiros Bioscience: Targeting Cancer with a Novel Antibody Drug Conjugate
Lajos Pusztai, MD, DPhil -
Sulabha Biopharmaceuticals
Mark A. Lemmon, Ph.D., FRS -
GlimmerX: Global ImmunoDiagnostics
Joseph Vinetz, MD, FACP, FIDSA, FASTMH, BS -
AtiasPharma: Developing New Therapeutic Agents Targeting Endocrine FCFs and their Cellular Pathways
Joseph Schlessinger, PhD -
Combatting Obesity Through a Novel Mechanism
Jonathan Bogan, M.D.